According to a recent LinkedIn post from Monarch Medical Technologies, the company is directing hospitals to a Centers for Medicare & Medicaid Services (CMS) Glycemic Safety Readiness Assessment offered by Glooko. The brief online tool is described as producing a readiness score, flagging workflow and governance gaps, and outlining next steps to improve glycemic safety reporting.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that, with CMS reporting already in progress, nursing workflows have become a key determinant of performance in glycemic safety metrics. It also emphasizes alignment with CMS definitions for severe hypo- and hyperglycemia, implying that hospitals may face operational and compliance risks if they are not properly calibrated to these standards.
For investors, this focus on CMS glycemic safety readiness underscores ongoing demand for analytics, workflow optimization, and clinical decision-support tools around inpatient glucose management. Monarch’s association with this type of assessment may position it to benefit from hospitals’ need to meet evolving reporting requirements, potentially supporting adoption of its glycemic management solutions and strengthening its role in quality- and safety-driven purchasing decisions.

